The Association of Donor Thyroid Hormone Supplementation on Heart Transplant Recipient Survival

Table 3

Survival associations for various predictors across four models are adjusted for donor age, BMI, ethnicity, ischemic time, and steriod use, as well as recipient age, BMI, ethnicity, LOS, region, VAD, creatinine, and days on waiting list.

	Death within 30 d (OR)	Death within 1 yr (OR)	Overall survival (HR)	Post-tx rejection (HR)
THS vs. none (pooled over sex)	0.88 (0.79, 0.99)	1.00 (0.93, 1.07)	0.94 (0.91, 0.97)	0.96 (0.93, 0.99)
THS vs. none (male donor ->male recipient)	0.81 (0.70, 0.94)	1.00 (0.91, 1.09)	0.93 (0.90, 0.97)	0.96 (0.92, 1.00)
THS vs. none (female donor ->female recipient)	0.90 (0.68, 1.19)	0.99 (0.84, 1.18)	0.88 (0.80, 0.96)	0.90 (0.82, 0.98)
THS vs. none (female donor ->male recipient)	1.14 (0.88, 1.49)	0.97 (0.82, 1.14)	0.99 (0.91, 1.07)	0.99 (0.91, 1.07)
THS vs. none (male donor ->female recipient)	0.94 (0.66, 1.33)	1.08 (0.87, 1.34)	1.01 (0.91, 1.12)	1.02 (0.92, 1.12)

OR = odds ratio; HR = hazard ratio; THS: thyroid hormone supplementation. Bold values are where significance was demonstrated.